Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 2
1983 5
1984 7
1985 8
1986 4
1987 21
1988 17
1989 24
1990 21
1991 24
1992 32
1993 16
1994 24
1995 29
1996 19
1997 44
1998 37
1999 55
2000 41
2001 30
2002 42
2003 31
2004 26
2005 36
2006 35
2007 42
2008 42
2009 59
2010 56
2011 55
2012 43
2013 49
2014 50
2015 53
2016 43
2017 36
2018 46
2019 50
2020 24
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

1,201 results
Results by year
Filters applied: . Clear all
Page 1
Systematic review: safety of mesalazine in ulcerative colitis.
Sehgal P, Colombel JF, Aboubakr A, Narula N. Sehgal P, et al. Aliment Pharmacol Ther. 2018 Jun;47(12):1597-1609. doi: 10.1111/apt.14688. Epub 2018 May 3. Aliment Pharmacol Ther. 2018. PMID: 29722441
BACKGROUND: Mesalazine is the most commonly prescribed medication for mild to moderate ulcerative colitis. It is generally well tolerated with some reported side effects. AIM: To summarise adverse drug events to mesalazine and recommend techniques for management. .. …
BACKGROUND: Mesalazine is the most commonly prescribed medication for mild to moderate ulcerative colitis. It is generally well tolerated wi …
The culprit of mesalamine intolerance: case series and literature review.
Xie C, Quan R, Hong F, Zou K, Yan W, Fu Y. Xie C, et al. BMC Gastroenterol. 2019 Jul 31;19(1):138. doi: 10.1186/s12876-019-1049-2. BMC Gastroenterol. 2019. PMID: 31366329 Free PMC article. Review.
It is interesting to found that the patients with excipients intolerance mainly presented with acute skin symptoms, such as skin rash, urticaria and angioedema. But the adverse effects of 5-ASA in previous reports include fever, headache, rash, nausea, vomiti …
It is interesting to found that the patients with excipients intolerance mainly presented with acute skin symptoms, such as skin rash, urtic …
Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.
Wang Y, Parker CE, Bhanji T, Feagan BG, MacDonald JK. Wang Y, et al. Cochrane Database Syst Rev. 2016 Apr 21;4(4):CD000543. doi: 10.1002/14651858.CD000543.pub4. Cochrane Database Syst Rev. 2016. PMID: 27101467 Free PMC article. Updated. Review.
BACKGROUND: Oral 5-aminosalicylic acid (5-ASA) preparations were intended to avoid the adverse effects of sulfasalazine (SASP) while maintaining its therapeutic benefits. ...There were no statistically significant differences in the incidence of adv
BACKGROUND: Oral 5-aminosalicylic acid (5-ASA) preparations were intended to avoid the adverse effects of sulfas …
Modern use of 5-aminosalicylic acid compounds for ulcerative colitis.
Le Berre C, Roda G, Nedeljkovic Protic M, Danese S, Peyrin-Biroulet L. Le Berre C, et al. Expert Opin Biol Ther. 2020 Apr;20(4):363-378. doi: 10.1080/14712598.2019.1666101. Epub 2019 Sep 18. Expert Opin Biol Ther. 2020. PMID: 31498003 Review.
Introduction: For 30 years, 5-aminosalicylic acid (5-ASA) has been the backbone of therapeutic management in patients with ulcerative colitis (UC). ...High-dose 5-ASA therapy may be a valuable option for patients with moderately active disease, and physicians …
Introduction: For 30 years, 5-aminosalicylic acid (5-ASA) has been the backbone of therapeutic management in patients with ulc …
American Gastroenterological Association Institute Guideline on the Management of Acute Diverticulitis.
Stollman N, Smalley W, Hirano I; AGA Institute Clinical Guidelines Committee. Stollman N, et al. Gastroenterology. 2015 Dec;149(7):1944-9. doi: 10.1053/j.gastro.2015.10.003. Epub 2015 Oct 8. Gastroenterology. 2015. PMID: 26453777 No abstract available.
The Association of Mesalamine With Kidney Disease.
Adiga A, Goldfarb DS. Adiga A, et al. Adv Chronic Kidney Dis. 2020 Jan;27(1):72-76. doi: 10.1053/j.ackd.2019.09.002. Adv Chronic Kidney Dis. 2020. PMID: 32147005 Review.
The package inserts for products containing 5-aminosalicylic acid, or mesalamine, include the following language regarding the risk of adverse kidney effects: "renal impairment, including minimal change nephropathy, acute and chronic interstitial nephr …
The package inserts for products containing 5-aminosalicylic acid, or mesalamine, include the following language regarding the …
Enteral nutrition for maintenance of remission in Crohn's disease.
Akobeng AK, Zhang D, Gordon M, MacDonald JK. Akobeng AK, et al. Cochrane Database Syst Rev. 2018 Aug 11;8(8):CD005984. doi: 10.1002/14651858.CD005984.pub3. Cochrane Database Syst Rev. 2018. PMID: 30098021 Free PMC article.
No serious adverse events or withdrawals due to adverse events were reported. ...It is unclear if any participants in the mesalamine group had an adverse event. Height, QoL, serious adverse events and withdrawal due to adverse events were …
No serious adverse events or withdrawals due to adverse events were reported. ...It is unclear if any participants in the m
Inflammatory bowel disease: clinical aspects and established and evolving therapies.
Baumgart DC, Sandborn WJ. Baumgart DC, et al. Lancet. 2007 May 12;369(9573):1641-57. doi: 10.1016/S0140-6736(07)60751-X. Lancet. 2007. PMID: 17499606 Review.
In this paper we discuss the current diagnostic approach, their pathology, natural course, and common complications, the assessment of disease activity, extraintestinal manifestations, and medical and surgical management, and provide diagnostic and therapeutic algorithms. We crit …
In this paper we discuss the current diagnostic approach, their pathology, natural course, and common complications, the assessment of disea …
Probiotics for induction of remission in ulcerative colitis.
Kaur L, Gordon M, Baines PA, Iheozor-Ejiofor Z, Sinopoulou V, Akobeng AK. Kaur L, et al. Cochrane Database Syst Rev. 2020 Mar 4;3(3):CD005573. doi: 10.1002/14651858.CD005573.pub3. Cochrane Database Syst Rev. 2020. PMID: 32128795
Twelve of the studies looked at adult participants and two studies looked at paediatric participants with mild to moderate ulcerative colitis, the average age was between 12.5 and 47.7 years. The studies compared probiotics to placebo, probiotics to 5-ASA and a comb …
Twelve of the studies looked at adult participants and two studies looked at paediatric participants with mild to moderate ulcerative coliti …
Comparative efficacy and tolerability of pharmacological agents for management of mild to moderate ulcerative colitis: a systematic review and network meta-analyses.
Nguyen NH, Fumery M, Dulai PS, Prokop LJ, Sandborn WJ, Murad MH, Singh S. Nguyen NH, et al. Lancet Gastroenterol Hepatol. 2018 Nov;3(11):742-753. doi: 10.1016/S2468-1253(18)30231-0. Epub 2018 Aug 17. Lancet Gastroenterol Hepatol. 2018. PMID: 30122356 Free PMC article.
Studies were included if patients were treated with oral sulfasalazine, diazo-bonded 5-aminosalicylates (5-ASAs), mesalazine (low dose <2 g/day, standard dose 2-3 g/day, or high dose >3 g/day), controlled ileal-release budesonide, or budesonide multimatrix, al …
Studies were included if patients were treated with oral sulfasalazine, diazo-bonded 5-aminosalicylates (5-ASAs), mesalazine ( …
1,201 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback